Drug repositioning ...
 
Notifications
Clear all

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer


Daniel
(@daniel)
Admin
Joined: 6 years ago
Posts: 1046
Topic starter  

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641118/

Also read this  https://www.cancertreatmentsresearch.com/bisphosphonates/ and this  https://www.cancertreatmentsresearch.com/reduce-cholesterol-in-cancer-cells-to-fight-cancer/


Quote
Share: